# Juniper Biologics Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/juniper-biologics-pte

- Industry: Pharmaceuticals
- Headquarters: Singapore, Singapore
- Website: www.juniperbiologics.com
- Total disclosed funding: $10M
- Latest round: Series A (Jan 4, 2023)
- Investors on record: 1

## About

Based in Singapore, Juniper Biologics Pte. Ltd. operates as a healthcare company that specializes in the development of medicine for cancer, rare diseases, and gene therapy. In February 2022, The Sylvan Group acquired a majority stake in Juniper Biologics Pte. Ltd. The company has commercial operations in China, Japan, Asia, Australia & New Zealand, Middle East & Africa.

The company develops drugs for oncology, rare/orphan diseases, cell and gene therapy to treat osteoarthritis through the regeneration of cartilage.

## Funding rounds

- Series A, Jan 4, 2023, $10M — UOB Venture Management

## Investors

- UOB Venture Management (https://capitalatlas.ai/funds/uob-venture-management) — Series A